- call +1-201-465-4211
- email sales@mrinsights.biz
The MMR vaccine (also known as the MPR vaccine after the Latin names of the diseases) is an immunization vaccine against measles, mumps, and rubella (German measles). It is a mixture of live attenuated viruses of the three diseases, administered via injection. It was first developed by Maurice Hilleman while at Merck.
Scope of the Report:
This report focuses on the MMR Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Measles, mumps, and rubella are the three common contagious airborne diseases that are highly caused by virus transmitted by sneezing and coughing of the infected person, which could lead to serious complications or death among children. Vaccines of these diseases are sold as attenuated viral vaccines, manufactured in a lyophilised formulation, which requires reconstitution with water for injection diluent and are available in two forms i.e. monovalent as well as combinational vaccines. Combinational MMR vaccines comprises mixture of two or more viral strains. These measles, mumps, and rubella vaccines are administered by subcutaneous injection to children as well as adults.
The worldwide market for MMR Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
GlaxoSmithKline
Medlmmune
Merck
Sanofi Pasteur
Serum Institute
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Monovalent
Combinational
Divalent
Trivalent
Market Segment by Applications, can be divided into
Pediatrics
Adolescents
Adults
Elderly
There are 15 Chapters to deeply display the global MMR Vaccines market.
Chapter 1, to describe MMR Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of MMR Vaccines, with sales, revenue, and price of MMR Vaccines, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of MMR Vaccines, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, MMR Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe MMR Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 MMR Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Monovalent
1.2.2 Combinational
1.2.3 Divalent
1.2.4 Trivalent
1.3 Market Analysis by Applications
1.3.1 Pediatrics
1.3.2 Adolescents
1.3.3 Adults
1.3.4 Elderly
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 Business Overview
2.1.2 MMR Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GlaxoSmithKline MMR Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Medlmmune
2.2.1 Business Overview
2.2.2 MMR Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Medlmmune MMR Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 MMR Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck MMR Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi Pasteur
2.4.1 Business Overview
2.4.2 MMR Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Pasteur MMR Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Serum Institute
2.5.1 Business Overview
2.5.2 MMR Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Serum Institute MMR Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global MMR Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global MMR Vaccines Sales and Market Share by Manufacturer (2016-2017)
3.2 Global MMR Vaccines Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 MMR Vaccines Manufacturer Market Share in 2017
3.3.2 Top 6 MMR Vaccines Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global MMR Vaccines Market Analysis by Regions
4.1 Global MMR Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global MMR Vaccines Sales and Market Share by Regions (2013-2018)
4.1.2 Global MMR Vaccines Revenue and Market Share by Regions (2013-2018)
4.2 North America MMR Vaccines Sales and Growth Rate (2013-2018)
4.3 Europe MMR Vaccines Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific MMR Vaccines Sales and Growth Rate (2013-2018)
4.5 South America MMR Vaccines Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa MMR Vaccines Sales and Growth Rate (2013-2018)
5 North America MMR Vaccines by Countries
5.1 North America MMR Vaccines Sales, Revenue and Market Share by Countries
5.1.1 North America MMR Vaccines Sales and Market Share by Countries (2013-2018)
5.1.2 North America MMR Vaccines Revenue and Market Share by Countries (2013-2018)
5.2 United States MMR Vaccines Sales and Growth Rate (2013-2018)
5.3 Canada MMR Vaccines Sales and Growth Rate (2013-2018)
5.4 Mexico MMR Vaccines Sales and Growth Rate (2013-2018)
6 Europe MMR Vaccines by Countries
6.1 Europe MMR Vaccines Sales, Revenue and Market Share by Countries
6.1.1 Europe MMR Vaccines Sales and Market Share by Countries (2013-2018)
6.1.2 Europe MMR Vaccines Revenue and Market Share by Countries (2013-2018)
6.2 Germany MMR Vaccines Sales and Growth Rate (2013-2018)
6.3 UK MMR Vaccines Sales and Growth Rate (2013-2018)
6.4 France MMR Vaccines Sales and Growth Rate (2013-2018)
6.5 Russia MMR Vaccines Sales and Growth Rate (2013-2018)
6.6 Italy MMR Vaccines Sales and Growth Rate (2013-2018)
7 Asia-Pacific MMR Vaccines by Countries
7.1 Asia-Pacific MMR Vaccines Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific MMR Vaccines Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific MMR Vaccines Revenue and Market Share by Countries (2013-2018)
7.2 China MMR Vaccines Sales and Growth Rate (2013-2018)
7.3 Japan MMR Vaccines Sales and Growth Rate (2013-2018)
7.4 Korea MMR Vaccines Sales and Growth Rate (2013-2018)
7.5 India MMR Vaccines Sales and Growth Rate (2013-2018)
7.6 Southeast Asia MMR Vaccines Sales and Growth Rate (2013-2018)
8 South America MMR Vaccines by Countries
8.1 South America MMR Vaccines Sales, Revenue and Market Share by Countries
8.1.1 South America MMR Vaccines Sales and Market Share by Countries (2013-2018)
8.1.2 South America MMR Vaccines Revenue and Market Share by Countries (2013-2018)
8.2 Brazil MMR Vaccines Sales and Growth Rate (2013-2018)
8.3 Argentina MMR Vaccines Sales and Growth Rate (2013-2018)
8.4 Colombia MMR Vaccines Sales and Growth Rate (2013-2018)
9 Middle East and Africa MMR Vaccines by Countries
9.1 Middle East and Africa MMR Vaccines Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa MMR Vaccines Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa MMR Vaccines Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia MMR Vaccines Sales and Growth Rate (2013-2018)
9.3 UAE MMR Vaccines Sales and Growth Rate (2013-2018)
9.4 Egypt MMR Vaccines Sales and Growth Rate (2013-2018)
9.5 Nigeria MMR Vaccines Sales and Growth Rate (2013-2018)
9.6 South Africa MMR Vaccines Sales and Growth Rate (2013-2018)
10 Global MMR Vaccines Market Segment by Type
10.1 Global MMR Vaccines Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global MMR Vaccines Sales and Market Share by Type (2013-2018)
10.1.2 Global MMR Vaccines Revenue and Market Share by Type (2013-2018)
10.2 Monovalent Sales Growth and Price
10.2.1 Global Monovalent Sales Growth (2013-2018)
10.2.2 Global Monovalent Price (2013-2018)
10.3 Combinational Sales Growth and Price
10.3.1 Global Combinational Sales Growth (2013-2018)
10.3.2 Global Combinational Price (2013-2018)
10.4 Divalent Sales Growth and Price
10.4.1 Global Divalent Sales Growth (2013-2018)
10.4.2 Global Divalent Price (2013-2018)
10.5 Trivalent Sales Growth and Price
10.5.1 Global Trivalent Sales Growth (2013-2018)
10.5.2 Global Trivalent Price (2013-2018)
11 Global MMR Vaccines Market Segment by Application
11.1 Global MMR Vaccines Sales Market Share by Application (2013-2018)
11.2 Pediatrics Sales Growth (2013-2018)
11.3 Adolescents Sales Growth (2013-2018)
11.4 Adults Sales Growth (2013-2018)
11.5 Elderly Sales Growth (2013-2018)
12 MMR Vaccines Market Forecast (2018-2023)
12.1 Global MMR Vaccines Sales, Revenue and Growth Rate (2018-2023)
12.2 MMR Vaccines Market Forecast by Regions (2018-2023)
12.2.1 North America MMR Vaccines Market Forecast (2018-2023)
12.2.2 Europe MMR Vaccines Market Forecast (2018-2023)
12.2.3 Asia-Pacific MMR Vaccines Market Forecast (2018-2023)
12.2.4 South America MMR Vaccines Market Forecast (2018-2023)
12.2.5 Middle East and Africa MMR Vaccines Market Forecast (2018-2023)
12.3 MMR Vaccines Market Forecast by Type (2018-2023)
12.3.1 Global MMR Vaccines Sales Forecast by Type (2018-2023)
12.3.2 Global MMR Vaccines Market Share Forecast by Type (2018-2023)
12.4 MMR Vaccines Market Forecast by Application (2018-2023)
12.4.1 Global MMR Vaccines Sales Forecast by Application (2018-2023)
12.4.2 Global MMR Vaccines Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure MMR Vaccines Picture
Table Product Specifications of MMR Vaccines
Figure Global Sales Market Share of MMR Vaccines by Types in 2017
Table MMR Vaccines T
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
